(Total Views: 128)
Posted On: 07/09/2021 10:05:49 AM
Post# of 27300

$GALT News Article - Galectin Therapeutics Announces Positive Top-Line Results from a Phase 1b Clinical Trial Extension of Belapectin in Combination with KEYTRUDA in Advanced Metastatic Melanoma and Head and Neck Cancer https://marketwirenews.com/news-releases/gale...45132.html


My Twitter: WhyteStocks